The medication is the only immuno-oncology drug approved by various regulatory ... the drug firm to expand the scope of the license to cover Australia, New Zealand and nine other countries.

What is a cover letter? A cover letter is a professional communication that should accompany your resume when you apply for a job or internship. A cover letter is the first piece of information a ...

UX cover letters are short letters or emails that designers send with their portfolios and resumes to apply for jobs. Designers personalize these to introduce themselves and briefly explain why they ...

Jazz Pharma has bolstered its pipeline of cancer drugs through a $1.3 billion licensing agreement with Werewolf Therapeutics that adds its first immuno-oncology candidate. The Dublin-based pharma ...

Indian drugmaker Dr Reddy’s Laboratories has launched its toripalimab in the domestic market, sending the firm’s share up 2%.

Dr Reddy’s Laboratories on November 28 launched India's first immuno-oncology drug, Toripalimab, to treat a rare form of cancer. The drug is approved for the treatment of nasopharyngeal ...

The Japanese pharma has been building a presence in oncology over the last few years through products such as its Adcetris (brentuximab vedotin), and its $5.2 billion acquisition of Ariad at the ...

ICE purchased more than $20 million worth of mobile surveillance tools just months before the election of a president who has vowed to undertake the largest mass deportation effort in U.S. history.

“It is the only immuno-oncology drug approved by various regulatory authorities around the world such as the United States Food and Drug Administration (USFDA), European Medicines Agency (EMA ...

Dr Reddy’s Laboratories launches Toripalimab, the first immuno-oncology drug for nasopharyngeal ... s to expand the scope of the license to cover Australia, New Zealand and nine other countries.

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Hedge Funds. In this article, we are going to ...